A patient undergoing anaesthesia for coronary artery bypass surgery developed what was subsequently confirmed to be an anaphylactic reaction to succinylated gelatin (Gelofusine ® ). By virtue of being on cardiopulmonary bypass, rapid detection, quantification and treatment of volume loss (by vasodilatation and extravasation) was possible. The patient required 51 ml/kg of resuscitative fluids in the 15 minutes after onset of anaphylaxis, or 73% of her calculated preoperative blood volume. Alpha-adrenoceptor agonists and vasopressin were required to manage ongoing vasoplegia. This case emphasises the importance of volume resuscitation and vasopressors in the treatment of anaphylaxis.
One of the mainstays in the treatment of cardiovascular collapse in anaphylaxis is aggressive fluid administration. Mediators released during anaphylaxis produce peripheral vasodilatation and increase capillary permeability resulting in a mixed distributive-hypovolaemic shock pattern 1 .
This report outlines a case of confirmed Gelofusine ® -induced (succinylated gelatin, B. Braun, Bella Vista, New South Wales, Australia) anaphylaxis during cardiopulmonary bypass (CPB) and offers an insight into the resulting changes in volume status and haemodynamics during the ensuing cardiovascular collapse.
Hypotension results from either a fall in cardiac output or systemic vascular resistance (SVR). This case is unique as the cardiac output was relatively fixed because the patient was on CPB. The assessment of haemodynamic changes seen in this case was further assisted by the monitoring of the CPB reservoir volume. This allowed rapid quantification of the volume loss associated with vasodilatation and extravasation.
CASE HISTORY
A 76-year-old female was admitted with an ischaemic left leg and subsequently underwent aboveknee amputation. Her other medical conditions included paroxysmal atrial fibrillation, hypertension, hypercholesterolaemia, peripheral vascular disease, type 2 diabetes mellitus and chronic renal impairment. Her only allergic history was the development of a pruritic rash after penicillin administration for a chest infection 10 years previously.
Her postoperative course was complicated by acute pulmonary oedema and a silent non-STsegment-elevation myocardial infarction. Subsequent investigations demonstrated triple-vessel coronary artery stenosis with mild hypokinesis of the apical septum but otherwise preserved left ventricular systolic and diastolic function with normal heart valves.
Two months after admission she was scheduled for coronary artery bypass grafting with CPB using saphenous vein and internal mammary artery grafts. Her weight was 72 kg and preoperative haemoglobin concentration (Hb) measured 103 g/l.
Induction of anaesthesia was uneventful and coronary artery grafting, while on CPB, was without incident. Her initial Hb after commencement of CPB was 57 g/l, and three units of packed cells were transfused. After an aortic cross-clamp time of 45 minutes she was rewarmed and prepared for separation from bypass. Reservoir volume was low at this point and following 1000 ml of Plasma-Lyte (Baxter, Toongabbie, New South Wales, Australia) she was transfused 500 ml of Gelofusine.
Within one minute of commencement of the Gelofusine bolus her mean arterial blood pressure fell from 60 mmHg to 30 mmHg and the return to the reservoir of the bypass circuit decreased. There was a concurrent fall in the patient's central venous pressure from 8 to 3 mmHg. Surgical and circuit-related causes of low venous return were excluded and a presumptive diagnosis of Gelofusine anaphylaxis was made ( Figure 1 ).
The Gelofusine infusion was ceased and hydrocortisone 200 mg was administered. Over the next 15 minutes, the patient received adrenaline in 100 to 500 µg boluses to a total of 3 mg and phenylephrine in 500 µg boluses to a total of 3 mg. Noradrenaline and adrenaline infusions were commenced. She was also aggressively resuscitated with intravenous fluids, receiving four units of packed red cells, two units of fresh frozen plasma and two litres of crystalloid. Despite these measures to correct venodilatation and extravasation of fluid, minimum volumes in the CPB reservoir were barely maintained even at low flows (1.5 l/ minute/m 2 ).
Thirty minutes after the administration of Gelofusine, the patient's condition began to improve with a more stable mean arterial blood pressure, a rise in central venous pressure and improved return to the bypass reservoir allowing higher flows to be achieved (2.0 l/ minute/m 2 ). At 50 minutes, separation from bypass was achieved. Post-CPB haemodynamic measurements found the patient to be vasodilated, with a SVR of 850 dyn.s.cm -5 and cardiac index of 3.5 l/ minute/m 2 . Transoesophageal echocardiography demonstrated a hyperdynamic, relatively empty left ventricle with preserved systolic and diastolic function. A vasopressin infusion was commenced. Heparinisation was then reversed with protamine. The patient's chest was closed and her condition continued to improve.
Prior to transfer from theatre her SVR had increased marginally to 950 dyn.s.cm -5 and her cardiac index had remained relatively constant at 3.3 l/minute/m 2 .
The patient was transferred to the intensive care unit and was extubated 24 hours later. She had significant peripheral oedema which resolved over several days and made a complete recovery with no neurological deficit. She was discharged from hospital two weeks after surgery.
Mast cell tryptase levels peaked at 36.4 µg/l (normal <14 µg/l), one hour after the onset of the anaphylaxis. Two months after surgery, allergy testing was undertaken. Skin prick and intradermal skin testing, using Fisher's Protocols 2 , confirmed Gelofusine as the causative agent with marked serpiginous weals with surrounding flares developing at both Gelofusine test sites.
Consent was obtained from the patient to publish this report.
DISCUSSION
Gelofusine allergy is well described, usually occurring during anaesthesia or resuscitation 3-6 . This often makes diagnosis and treatment difficult due to confounding pathophysiological states. The exact mechanism is largely unknown, but both IgE and non-IgE mechanisms have been postulated 5 . It is estimated that the incidence of allergic reactions to gelatin-based solutions is 0.038% 7 .
In this case, adrenaline 3 mg, phenylephrine 3 mg and 3680 ml of fluid (four units packed red cells, two units FFP and 2 litres Plasmalyte) were given in the first 15 minutes of the reaction to maintain reservoir levels.
We estimated her normal circulating blood volume to be 5.04 litres, assuming that blood volume is 70 ml/kg in the non-obese 8 . The volume of the bypass circuit was 2.4 litres. The volume of resuscitation fluids given in the first 15 minutes therefore represented 49.4% of her circulating CPB volume or 73% of her estimated blood volume by weight. This was despite aggressive co-administration of adrenaline and vasoconstrictors.
In addition to hypovolaemia and maldistribution of blood, the mechanisms of shock in anaphylaxis are postulated to include cardiac dysfunction from poor venous return as well as the direct effects of anaphylactic mediators on the myocardium causing depressed contractility 1, 9 . Pulmonary vasospasm has also been implicated in obstruction to filling of the left ventricle 10 . The circumstances of this case are novel in that the patient's heart and lungs were largely isolated from the systemic circulation during the period of distributive-hypovolaemic shock. The hypotension was clearly the result of reduced venous return to the CPB circuit and decreased systemic vascular resistance, as the cardiac output was fixed.
The second novel aspect of this case was that it was possible to directly measure the expansion of intravascular volume required to maintain the venous reservoir volume. In the treatment of anaphylaxis, the exact requirement for fluid resuscitation is not known. Maldistribution due to venodilatation and hypovolaemia secondary to increased capillary permeability and plasma extravasation contribute to circulatory shock. The component resulting from plasma losses in the first 10 minutes has been estimated to be as high as 35% of the circulating blood volume, as inferred from changes in the haemoglobin concentrations of 22 patients having acute anaphylactic reactions 9, 11 . The volume of fluid administered in this case was much greater, and may possibly reflect measurement of the additional requirements due to blood pooling from venodilatation.
Current guidelines for fluid resuscitation in acute anaphylaxis indicate that large volumes may be required, recommending multiple boluses of 10 to 20 ml/kg up to a total of 50 ml/kg over the first 30 minutes 9, 12 . This case, in which a total of 51 ml/kg of fluid was administered within 15 minutes of the trigger for anaphylaxis, supports these recommendations.
Although a large number of preformed and generated mediators have been implicated in anaphylaxis, resulting in the concept of the mast cellleucocyte cytokine cascade 9 , it is the histamine level that is most closely correlated with the severity of the hypotension. Moss et al 13 measured a 20-fold increase in plasma histamine from normal after an anaphylactic reaction to suxamethonium, associated with a profound fall in the SVR. Although they measured a massive increase in endogenous catecholamine levels, it was not sufficient to attenuate the effect of the histamine. The case was unusual since resuscitation was with fluid alone with a return to normal haemodynamic parameters concomitant with a fall to normal in the plasma histamine level at around 20 minutes.
Loss of circulating volume in anaphylaxis is due to a combination of increased capillary permeability with fluid extravasation into the interstitial space and sequestration in grossly dilated vascular beds leading to a profound reduction in venous return. This mechanism was well demonstrated in this case by the transoesophageal echocardiogram showing an empty heart even after massive fluid replacement.
Adrenaline has mast cell stabilising and bronchodilating effects, clearly of benefit in the treatment of anaphylaxis. More recently there have been calls for guidelines in the treatment of anaphylaxis unresponsive to adrenaline to include the use of pure alpha agonists 14 . It is thought that this would more effectively treat the vasoplegia and reduce the risk of tachyarrhythmias and the beta 2induced vasodilatory effects of adrenaline. We would support this proposed change. A similar argument would support the earlier use of vasopressin, for which there are a number of case reports in the literature, one paper describing its role as 'pivotal' 15 .
This case highlights and reinforces the importance of volume replacement in anaphylaxis. It also serves as a reminder that gelatin-based colloids, which are most commonly resorted to in critical situations, may have undesirable effects. Our understanding of the physiological effects of histamine and the responses seen in this case would support the earlier use of alpha agonists and vasopressin.
